Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

Immunity(2020)10.1016/j.immuni.2020.10.023Source: DataRank Database

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity is a research paper published in Immunity (2020). On theSindex it has a DataRank of 0. It has been cited 241 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access241 citations

Download PDF

Cite:

Linked data & code

gen emdb gisaid pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 4.79)OA: hybridTopics (58)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Nicholas C. Wu ORCID,Meng Yuan ORCID,Sandhya Bangaru ORCID,Jonathan L. Torres ORCID,Tom G. Caniels ORCID

Live enrichment

PubMed:33242394 PMC:PMC7687367 OpenAlex:https://openalex.org/W3109842873

National Institute of General Medical Sciences

Grant: P41GM103393

National Institutes of Health

Grant: P01 AI110657

National Institutes of Health

Grant: UM1 AI44462

National Institutes of Health

Grant: K99 AI139445

Basic Energy Sciences

Grant: DE-AC02\u201376SF00515

Bill and Melinda Gates Foundation

Grant: OPP1170236

Bill and Melinda Gates Foundation

Grant: OPP1132237

Bill and Melinda Gates Foundation

Grant: INV-002022

Amsterdam University Medical Centers

Grant: 2020-039EP-PR

National Institutes of Health

Grant: 2P01AI110657-06

Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies

National Institutes of Health

Grant: 5K99AI139445-02

Mechanistic understanding of influenza-host interactions from a zoonotic perspective

National Institutes of Health

Grant: 8P41GM103393-33

A Synchroton Radiation Structural Biology Resource

SLAC National Accelerator Laboratory

Dutch Research Council (NWO)

Biological and Environmental Research

U.S. Department of Energy

Office of Science

FWCI

4.79

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.immuni.2020.10.023

publisherhttps://doi.org/10.1016/j.immuni.2020.10.023

publisherhttps://api.elsevier.com/content/article/PII:S1074761320304647?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761320304647?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33242394

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Broadly Neutralizing AntibodiesAngiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 VaccinesAntibodies, ViralCross ReactionsCrystallizationHumansImmunoglobulin Fab FragmentsProtein BindingProtein ConformationConserved SequenceEpitope MappingEpitopes, B-LymphocyteSevere acute respiratory syndrome-related coronavirusProtein Interaction Domains and Motifs

Keywords

AvidityEpitopeNeutralizationAntibodyBiologyVirologyGlycoproteinCoronavirusEpitope mappingCross-reactivityMolecular biologyImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)DiseaseMedicineCross reactionsCOVID-19 VaccinesProtein ConformationSARS-CoV-2COVID-19Antibodies, ViralArticleImmunoglobulin Fab FragmentsInfectious DiseasesSevere acute respiratory syndrome-related coronavirusImmunology and AllergyEpitopes, B-LymphocyteHumansProtein Interaction Domains and MotifsAngiotensin-Converting Enzyme 2CrystallizationBroadly Neutralizing AntibodiesConserved SequenceProtein Binding

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Life in Land

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699.v1figshare

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699figshare

Additional file 1 of Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review

10.6084/m9.figshare.20252899.v1figshare

Additional file 1 of Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review

10.6084/m9.figshare.20252899figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708.v1figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702.v1figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705.v1figshare